GB1349362A - Process for preparing live virus vaccines - Google Patents

Process for preparing live virus vaccines

Info

Publication number
GB1349362A
GB1349362A GB1085371A GB1085371A GB1349362A GB 1349362 A GB1349362 A GB 1349362A GB 1085371 A GB1085371 A GB 1085371A GB 1085371 A GB1085371 A GB 1085371A GB 1349362 A GB1349362 A GB 1349362A
Authority
GB
United Kingdom
Prior art keywords
vaccines
virus
april
virus vaccines
live virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1085371A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation for Microbial Diseases of Osaka University BIKEN
Original Assignee
Research Foundation for Microbial Diseases of Osaka University BIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation for Microbial Diseases of Osaka University BIKEN filed Critical Research Foundation for Microbial Diseases of Osaka University BIKEN
Publication of GB1349362A publication Critical patent/GB1349362A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

1349362 Virus vaccines; cultivating virus RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY 22 April 1971 [22 April 1970] 10853/71 Heading A5B [Also in Division C6] Viruses for the production of vaccines are cultivated in the usual way in embryonated quail egg or in a tissue culture of a quail embryo fibroplast, serial culture either wholly or partially in such media being used when an attenuated virus is required. Reference is made to the cultivation of the following viruses: rubella, mumps, influenza A and B, distemper, vaccinia, Newcastle disease, Japanese encephalites, dongue fever, rabies and Marek's disease.
GB1085371A 1970-04-22 1971-04-22 Process for preparing live virus vaccines Expired GB1349362A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3527470A JPS5013333B1 (en) 1970-04-22 1970-04-22

Publications (1)

Publication Number Publication Date
GB1349362A true GB1349362A (en) 1974-04-03

Family

ID=12437194

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1085371A Expired GB1349362A (en) 1970-04-22 1971-04-22 Process for preparing live virus vaccines

Country Status (9)

Country Link
JP (1) JPS5013333B1 (en)
BE (1) BE766093A (en)
CA (1) CA955850A (en)
CH (1) CH563459A5 (en)
DE (1) DE2119688C3 (en)
FR (1) FR2092068B1 (en)
GB (1) GB1349362A (en)
IT (1) IT1001467B (en)
NL (2) NL173598C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA743771B (en) * 1973-07-19 1975-07-30 M Sevoian Vaccine and preparation thereof

Also Published As

Publication number Publication date
IT1001467B (en) 1976-04-20
JPS5013333B1 (en) 1975-05-19
DE2119688C3 (en) 1980-04-24
NL173598C (en) 1984-02-16
CA955850A (en) 1974-10-08
FR2092068A1 (en) 1972-01-21
NL8303134A (en) 1984-01-02
DE2119688B2 (en) 1979-08-09
NL173598B (en) 1983-09-16
FR2092068B1 (en) 1977-04-15
DE2119688A1 (en) 1971-11-04
BE766093A (en) 1971-09-16
NL7105497A (en) 1971-10-26
CH563459A5 (en) 1975-06-30

Similar Documents

Publication Publication Date Title
ATE104698T1 (en) INFLUENZA VACCINE.
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
ES373631A1 (en) Live attenuated marek{40 s disease virus vaccine for poultry
US4571386A (en) Feline infectious peritonitis vaccine
GB1317710A (en) Poultry vaccine
US3961046A (en) Mumps vaccine and preparation thereof
GB1349362A (en) Process for preparing live virus vaccines
US3429965A (en) Avian pox virus vaccine and process of preparing same
Takemoto et al. Influence of acid polysaccharides on plaque formation by influenza A2 and B viruses
MacFarlane et al. Cultivation of toxoplasma in the developing chick embryo.
KR880001808A (en) Live infection of chicken infectious diseases (infectious laryngotracheitis and Marek's disease)
GB1229888A (en)
JPH0998778A (en) Marek's disease vaccine
GB1274820A (en) Highly attenuated newcastle disease virus vaccine and production thereof
GB930451A (en) Process for propagating rabies virus
Buddingh The chick embryo for the study of infection and immunity
Mack et al. Serological response in chickens to beta-propiolactone treated Newcastle disease virus
US3418210A (en) Hamster ascites tumor cell line bhk 21/c.13/t.6/ascites useful in submerged serum-free agar cultures to support virus growth
Melendez et al. Multiplication of foot and mouth disease virus in adult kidney, and embryonic lung and heart bovine tissue cultures
GB1133958A (en) Process for the manufacture of a distemper vaccine
GB1015262A (en) Virus culture
GB1070764A (en) Improvements in or relating to a process for culturing tissue cells
GB1279859A (en) Process for the production of enhanced levels of viral yield
GB1324618A (en) Infectious coryza infectious bronchitis and newcastle disease vaccines
Janda et al. Variation in neurovirulence of NWS influenza virus after repeated passages in different tissue culture systems: I. Derivation and neurotropic activity of NWS virus lines

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee